ReviewScience advances2023
Challenges and strategies for commercialization and widespread practical applications of superhydrophobic surfaces.
Review in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Thermo-Photo Dual-Curing Enables Dense Polymer Networks Toward Robust and Fluorine-Free Superhydrophobic Coatings.Small methods · 2026Article
- Nondestructive removal of superhydrophobic coatings by an electric switch.Nature communications · 2026Article
- Photothermal superhydrophobic and corrosion resistant titania microstructured surface for ice prevention and removal.Nature communications · 2026Article
- One-step fabrication of superhydrophobic fabrics with stable mechanical performance in harsh conditions.Nature communications · 2026Article
- Roles of adhesives in forming mechanically robust superhydrophobic coatings.Chemical science · 2025Review
- Nanostructured Surfaces with Plasmonic Activity and Superhydrophobicity: Review of Fabrication Strategies and Applications.Small (Weinheim an der Bergstrasse, Germany) · 2025Review
- Enhancing Resistance to Wetting Transition through the Concave Structures.Advanced materials (Deerfield Beach, Fla.) · 2025Article
- Scalable robust photothermal superhydrophobic coatings for efficient anti-icing and de-icing in simulated/real environments.Nature communications · 2024Article
- A review on recent progress and techniques used for fabricating superhydrophobic coatings derived from biobased materials.RSC advances · 2024Review
- Recent Advances in Superhydrophobic Materials Development for Maritime Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Superhydrophobic (SH) surfaces have progressed rapidly in fundamental research over the past 20 years, but their practical applications lag far behind. In this perspective, we first present the findings of a survey on the current state of SH surfaces including fundamental research, patenting, and commercialization. On the basis of the survey and our experience, this perspective explores the challenges and strategies for commercialization and widespread practical applications of SH surfaces. The comprehensive performances, preparation methods, and application scenarios of SH surfaces are the major constraints. These challenges should be addressed simultaneously, and the actionable strategies are provided. We then highlight the standard test methods of the comprehensive performances including mechanical stability, impalement resistance, and weather resistance. Last, the prospects of SH surfaces in the future are discussed. We anticipate that SH surfaces may be widely commercialized and used in practical applications around the year 2035 through combination of the suggested strategies and input from both academia and industry.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.